ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1426	National Cancer Institute	Html	en	Childhood Ependymoma Treatment (PDQ®)–Health Professional Version	In childhood ependymoma, cancer forms in the tissues of the brain and spinal cord. The cause of ependymoma is unknown. Find out about the molecular and clinical features, diagnosis, prognosis, treatment, and clinical trials for pediatric ependymoma, subependymoma, myxopapillary ependymoma, anaplastic ependymoma, and RELA fusion–positive ependymoma.	childhood recurrent ependymoma 0.446141 Merchant TE 0.374501 Brain Tumor Registry 0.351132 childhood brain tumor 0.35242 spinal cord ependymomas 0.479172 nervous system ependymoma 0.395153 posterior fossa ependymoma 0.628195 brain tumors 0.516421 children 0.409198 malignant brain tumors 0.384396 newly diagnosed ependymoma 0.411931 Sayegh ET 0.377382 Int J Radiat 0.476989 Radiat Oncol Biol 0.6983 World Health Organization 0.41477 intracranial ependymoma recurrence 0.508211 pediatric supratentorial tumors 0.369961 posterior fossa tumors 0.3562 infratentorial ependymoma 0.423041 ependymoma patients 0.42421 intracranial ependymomas 0.39986 Supratentorial ependymoma 0.435338 Clin Cancer Res 0.386576 paediatric ependymoma 0.450128 pediatric intracranial ependymoma 0.570833	radiation therapy 0.449829 Acta Neuropathol 0.35243 et al. 0.743726 childhood ependymoma 0.513088 intracranial ependymoma 0.927373 recurrent ependymoma 0.45402 Neuro Oncol 0.356088 primary brain tumors 0.39985 pediatric intracranial ependymomas 0.371298 adult ependymoma cases 0.44321 Pediatr Blood Cancer 0.534048 childhood ependymomas 0.358916 Metastatic ependymoma 0.401089 posterior fossa ependymomas 0.381573 spinal cord 0.504643 Abstract 0.696 non-anaplastic ependymoma 0.396839 childhood intracranial ependymoma 0.687299 Clin Oncol 0.484182 childhood brain tumors 0.3515 Oncol Biol Phys 0.714533 spinal canal ependymoma 0.421296 Central Brain Tumor 0.351707 Childs Nerv Syst 0.489135	CLICK HERE
1488	National Cancer Institute	Html	en	Metastatic Squamous Neck Cancer With Occult Primary Treatment (PDQ®)–Health Professional Version	Metastatic squamous neck cancer with occult primary occurs when squamous cell cancer spreads to lymph nodes in the neck from an undetectable primary tumor. Treatment includes surgery and radiation therapy. Learn about the diagnosis, survival, staging, and treatment of these tumors.	primary site. 0.436234 moderately differentiated tumors 0.539497 Thyroid function testing 0.46762 massive homolateral adenopathy 0.465434 EBV genomic material 0.535385 metastatic carcinoma 0.482369 lymph node dissection 0.549764 probable primary site 0.571551 germ cell tumor 0.575226 PDQ cancer information 0.618029 cervical lymph nodes. 0.554105 poorly differentiated tumors 0.545473 entire thyroid gland 0.457464 cancer information summary 0.595141 Primary tumors 0.485135 palpable tumor 0.472764 breast cancer prevention 0.4696 adequate neck dissection 0.527836 primary physician 0.522652 patients 0.45154 poorly differentiated tumor 0.752934 fine-needle aspiration biopsy 0.484684 epstein-barr virus 0.506145 NCI PDQ cancer 0.504517 lower neck 0.447545	radiation therapy 0.728398 cervical nodal tissue 0.52026 squamous carcinoma 0.531992 magnetic resonance imaging 0.467707 neck mass 0.432409 DNA amplification 0.492378 metastatic squamous cell 0.564542 neck primary site 0.62075 germ cell malignancies 0.487658 metastatic lymph node 0.63625 overt nasopharyngeal carcinoma. 0.485019 cervical lymph node 0.754988 obvious metastatic disease 0.554252 polymerase chain reaction 0.487648 cervical node metastases 0.558588 Squamous carcinomas 0.45824 external-beam radiation therapy 0.502847 Periodic Acid Schiff 0.471213 unknown primary 0.44413 platinum-based combination chemotherapy 0.478329 undifferentiated carcinoma 0.456062 neck tumors 0.464529 occult primary tumor 0.948651 lymph node metastases 0.623031	CLICK HERE
1560	National Cancer Institute	Html	en	Bile Duct Cancer (Cholangiocarcinoma) Treatment (PDQ®)–Patient Version	Expert-reviewed information summary about the treatment of bile duct cancer.	cancer treatment 0.353124 bile ducts 0.564994 bile duct cancer 0.93969 body 0.371618 Recurrent bile duct 0.466297 extrahepatic bile duct 0.483916 PDQ cancer information 0.368 resectable perihilar bile 0.374861 perihilar bile duct 0.569945 clinical trial search 0.384576 bile duct 0.961515 clinical trials 0.565197 nearby lymph nodes 0.369687 cancer information summary 0.357079 resectable bile duct 0.431592 bile duct cancers 0.440742 liver 0.42559 patients 0.355382 clinical trial 0.45121 distal extrahepatic bile 0.464256 radiation therapy 0.471059 small intestine 0.398038 intrahepatic bile duct 0.502288 treatment 0.464058 transhepatic biliary drainage 0.355933	NCI-supported cancer 0.356212 cancer cells 0.412313 bile duct wall 0.415716 stage bile duct 0.454009 metastatic perihilar bile 0.377513 common bile duct 0.446017 National Cancer Institute 0.386156 Stent placement 0.359539 metastatic bile duct 0.439918 new treatment 0.359129 common hepatic duct 0.40199 external radiation therapy 0.3932 carry bile 0.373127 procedure 0.357714 swollen bile ducts 0.401928 cystic duct 0.364061 cancer clinical trials 0.390707 duct cancer cells 0.3797 resectable intrahepatic bile 0.377924 tumor 0.353722 intrahepatic bile ducts 0.394408 internal radiation therapy 0.382915 metastatic intrahepatic bile 0.380622 information 0.370053	CLICK HERE
1631	National Cancer Institute	Html	en	Merkel Cell Carcinoma Treatment (PDQ®)–Patient Version	Merkel cell carcinoma is a rare disease in which cancer cells form in Merkel cells in the skin and starts most often in areas of skin exposed to the sun. Find out about risk factors, symptoms, tests to diagnose, prognosis, staging, and treatment for Merkel cell carcinoma.	cancer treatment 0.369679 distant parts 0.362908 lymph node dissection 0.588951 body 0.395316 PDQ cancer information 0.408963 clinical trial search 0.383573 metastatic Merkel cell 0.359176 clinical trials 0.614596 nearby lymph nodes 0.400683 cancer information summary 0.387551 clinical trial 0.501642 Merkel cells 0.371884 tumor area 0.368378 patients 0.364556 lymph node biopsy 0.419179 sentinel lymph node 0.455835 radical lymph node 0.418343 Recurrent Merkel cell 0.378899 malignant tumor cells 0.373594 NCI PDQ cancer 0.361276 Treatment Option Overview 0.361132 lymph nodes 0.564493 radiation therapy 0.43011 Treatment Editorial Board 0.360626 general cancer information 0.354614	treatment 0.462922 wide local excision 0.414099 swollen lymph nodes 0.431138 NCI-supported cancer 0.355921 cancer cells 0.429285 Cancer Information Service 0.355025 treatment clinical trials 0.372695 National Cancer Institute 0.42114 Cell Carcinoma Treatment 0.359564 regional lymph node 0.418618 lymph vessels 0.377608 new treatment 0.401967 merkel cell carcinoma 0.969094 primary tumor 0.368519 cancer clinical trials 0.393874 stage 0.380167 cell lung cancer 0.358436 tumor 0.434689 comprehensive cancer information 0.354073 cancer 0.71533 information 0.409547 lymph ducts 0.372558 standard treatment 0.354595 physical exam 0.362972	CLICK HERE
1738	National Cancer Institute	Html	en	Angiogenesis Inhibitors	A fact sheet that describes the process of eliminating the blood supply to tumors. Lists the cancers in which this approach is being tested.	downstream signaling pathways 0.352285 cancer treatments 0.343078 endothelial cells 0.425301 normal endothelial cells 0.371999 ongoing clinical trials 0.354207 tumor blood vessels 0.37481 chemical signals 0.419755 Drug Administration 0.362362 nearby normal cells 0.358821 endothelial growth factors 0.369707 cancer cells 0.356859 VEGF receptor 0.345762 angiogenesis inhibitors 0.944406 inhibiting effects 0.333711 Finding NCI-Supported Clinical 0.352444 antiangiogenic agents 0.332621 synthetic angiogenesis inhibitors 0.552673 angiogenesis pathways 0.444579 new blood vessels 0.642431 endothelial growth factor 0.370427 rare side effects 0.352056 tumor-vascular disrupting agents 0.351163 tumor angiogenesis 0.466745 nci-supported clinical trials 0.386702	treatment clinical trials 0.356002 blood vessel growth 0.362373 metastatic colorectal cancer 0.362717 tumor growth 0.335181 clinical trials 0.464552 tumor cells 0.336152 U.S. Food 0.362379 renal cell cancer 0.360541 VEGF 0.349952 blood vessels 0.736003 angiogenesis inhibitor therapy 0.559395 blood vessel formation 0.363763 non-small cell lung 0.351539 normal body processes 0.348332 kidney cancer 0.365728 NCI Contact Center 0.349609 tumors 0.369989 cancer clinical trials 0.389068 blood supply 0.372039 human cancer 0.334753 conventional anticancer drugs 0.349958 cancer 0.433974 growth 0.373337	CLICK HERE
1977	National Cancer Institute	Html	es	Tratamiento del carcinoma de corteza suprarrenal (PDQ®)–Versión para pacientes	Resumen de revisión revisada por expertos acerca del tratamiento del carcinoma de corteza suprarrenal.	siguientes procedimientos 0.496457 tinte circula 0.500083 pequeña cantidad 0.426407 estadio ii 0.722852 vía oral 0.42258 rayos x 0.485722 ondas sonoras 0.428325 National Cancer Institute 0.418399 sustancia llamada gadolinio 0.451231 suprarrenal elabora hormonas 0.951617 siguientes riesgos 0.416128 secciones cáncer 0.564083 Instituto Nacional 0.51582 PDQ Tratamiento 0.443801 siguientes hormonas 0.456613	presente sección 0.419609 corteza suprarrenal causa 0.829807 siguientes funciones 0.454626 Physician Data Query 0.471125 médula suprarrenal.Ampliar 0.44071 estadio iii 0.71977 características masculinas 0.438548 siguientes enfermedades 0.449744 PDQ Feocromocitoma 0.493816 suprarrenal causa efectos 0.739636 siguientes terapias 0.423482 PDQ Cánceres 0.484481 siguientes enlaces 0.420507 suprarrenal funcionante elabora 0.710246 siguientes pruebas 0.503631	CLICK HERE
1994	National Cancer Institute	Html	es	Tratamiento del craneofaringioma infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del craneofaringioma infantil	childhood-onset craniopharyngioma 0.555421 Winkfield KM 0.461372 Merchant TE 0.538632 Pediatric Patients with 0.460492 largo plazo 0.456579 brain tumors 0.465364 cystic craniopharyngiomas 0.546839 pediatric craniopharyngiomas with 0.478389 after childhood-onset craniopharyngioma 0.509117 calcificación quizás 0.453393 craneofaringioma infantil grupo 0.448145 past treatment modalities 0.44452 Instituto Nacional 0.469284 Proton beam therapy 0.44785 proton radiotherapy 0.445521 Radiat Oncol Biol 0.691179 Pediatric Brain Tumor 0.463199 Endocrinol Metab 0.525086 Gebhardt U 0.460882 central nervous system 0.452583 proton therapy 0.48171 tumor control 0.4621 Optimal treatment strategy 0.445937 radiation therapy 0.847388 Clin Endocrinol Metab 0.477641	following treatment 0.481728 subtotal quizás 0.449448 Neurosurg Focus 0.603105 Pediatric MATCH 0.494065 pediatric craniopharyngioma 0.961568 tumores quísticos recidivantes 0.450542 PDQ Descripción 0.449293 Pediatr Blood Cancer 0.611837 after radiation therapy 0.60095 With Craniopharyngioma That 0.51489 efectos tardíos 0.785518 PDQ Efectos tardíos 0.471103 tumor control with 0.459757 Neurosurgical treatment 0.478026 National Cancer Institute 0.453747 with proton radiotherapy 0.445448 tumor quizás 0.486067 PDQ Tratamiento 0.463786 treatment strategy 0.478645 long-term results 0.483149 Oncol Biol Phys 0.703438 Neurosurg Pediatr 0.66815 long-term gh therapy 0.447185 patients with craniopharyngioma 0.738686	CLICK HERE
2006	National Cancer Institute	Html	es	Tratamiento del feocromocitoma y paraganglioma (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del tratamiento del feocromocitoma y el paraganglioma.	glándula tiroides 0.609278 glándulas suprarrenales ayuda 0.631749 siguientes procedimientos 0.696393 siguientes aspectos 0.575361 Neurofibromatosis tipo 0.579395 siguientes síndromes 0.595261 vía oral 0.53652 rayos x 0.649118 tumores neuroendocrinos 0.602024 National Cancer Institute 0.520886 paraganglioma causa efectos 0.753898 siguientes riesgos 0.518888 endocrina múltiple tipo 0.630502 feocromocitoma hereditario 0.929917	Instituto Nacional 0.540854 PDQ Tratamiento 0.549585 insuficiencia suprarrenal aguda 0.595836 Mucha sudación 0.56538 partes distantes 0.527507 Physician Data Query 0.586955 siguientes situaciones 0.586373 siguientes características 0.581278 von hippel-lindau 0.636326 TEP -FDG 0.553345 enfermedad.ampliar paraganglioma 0.655429 Períodos súbitos 0.521079 siguientes medicamentos 0.565161 siguientes pruebas 0.590766	CLICK HERE
2988	National Cancer Institute	Html	en	Secondhand Smoke	Smoking affects both you and your loved one's health. Learn about the consequences of secondhand smoke and how you can protect your family.	feet 0.409991 dangers 0.420271 Lung cancer 0.428942 good example 0.428021 non-smoker 0.407426 care staff 0.426607 nicotine affect 0.427281 babysitters 0.406286 body 0.411562 smoker 0.414092 children 0.431937 harms 0.407652 sure caretakers 0.428123 secondhand smoke 0.971613 non-smokers 0.43912 heart disease‚ 0.429635 Fact 0.410452 short time 0.429909 somebody 0.406088 health problems 0.428728 smokefree restaurants 0.432863 lung infections 0.428228 smoking indoors 0.445671 main way smoking 0.477206 Breathing problems 0.428866	indoor public places 0.450365 babies 0.424287 smokers 0.419121 air 0.417572 life 0.412446 Breathing secondhand smoke 0.5983 infant death syndrome 0.453829 smoking 0.508887 National Cancer Institute 0.448359 heart attack‚ 0.429618 kids 0.411336 quiz 0.411311 cigarette 0.405834 coughing‚ extra phlegm‚ 0.454984 bronchitis 0.405901 people 0.432125 home 0.416331 nannies 0.405803 severe attacks 0.428972 best thing 0.428251 shortness 0.406847 ear infections 0.428442 low birth weight 0.454001 family 0.425482	CLICK HERE
16645	National Cancer Institute	Html	en	Understanding “Chemobrain” and Cognitive Impairment after Cancer Treatment	An NCI research update about research to investigate what factors play a role in “chemobrain” or cognitive impairment after cancer treatment.	cognitive problems 0.439925 cognitive behavioral therapy 0.339182 cancer treatment 0.685512 cognitive effects 0.256058 self-reported cognitive functioning 0.391696 lower cognitive performance 0.348528 cognitive decline 0.284161 chemotherapy 0.377855 long-term cognitive changes 0.331518 chemotherapy treatment 0.254041 cognitive challenges 0.286627 cognitive issues 0.282189 Kettering Cancer Center 0.246129 chemotherapy-associated cognitive impairment 0.369163 Wilmot Cancer Institute 0.218061 Dr. Ganz 0.536508 Jonsson Comprehensive Cancer 0.230946	Dr. Ahles 0.527642 cognitive rehabilitation program 0.323502 cognitive changes 0.469428 healthy women 0.234218 breast cancer patients 0.251612 recent research 0.354647 patients 0.34223 Cancer Therapy-Cognitive Function 0.218486 breast cancer survivors 0.783509 cognitive difficulties 0.366868 treatment-related cognitive impairment 0.464189 hormonal therapy 0.233078 self-reported cognitive complaints 0.381226 cognitive symptoms 0.25427 cognitive impairment 0.941275 neuropsychological tests 0.263188	CLICK HERE